PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Milk thistle, taken by many people for liver disease, ineffective as treatment for hepatitis C

2012-07-18
(Press-News.org) CHAPEL HILL, N.C. – Silymarin or "milk thistle," a popular herbal dietary supplement that many people take for liver ailments, works no better than placebo in patients with chronic hepatitis C infection.

That's the conclusion of a multicenter clinical trial published in the July 18, 2012 issue of the Journal of the American Medical Association.

"Patients ask me about milk thistle all the time," said Michael W. Fried, MD, lead author of the study, a professor in the University of North Carolina School of Medicine and director of the UNC Liver Center.

"Now I can tell them with great confidence that taking milk thistle, unfortunately, won't help for chronic hepatitis C," he said. "I think this information is very important to help patients focus on other ways to maintain liver health and not rely on ineffective remedies."

Roy Hawke, PharmD, PhD, assistant dean of the UNC Eshelman School of Pharmacy, is a co-author of the study.

In the study, 154 people with chronic hepatitis C who had shown no improvement after conventional interferon-based therapy were randomly assigned to receive 420-mg or 720-mg doses of silymarin, or matching placebo, 3 times a day for 24 weeks.

At the end of 24 weeks, only 2 patients in each of the three treatment groups met the main outcome measure of the study, which was normalization or a minimum 50 percent decline from baseline in serum alanine aminotransferase (ALT) levels. Low levels of ALT are normally found in the blood while higher levels indicate liver damage or liver disease. There were no significant differences in response between the three groups. Quality of life measures were also unchanged.

Many different formulations of silymarin or milk thistle are available for purchase in the U.S. without prescription. The study used a very high quality European formulation that was given in doses 3 to 5 times larger than customary, Fried said.

"This was the strongest, most methodologically sound clinical trial to date of silymarin as a treatment for chronic hepatitis C infection, and we found that it had absolutely no effect on serum ALT or levels of the hepatitis C virus," Fried said. "That was a surprise to us. We expected it to show at least some effect."



INFORMATION:

In addition to Fried and Hawke, authors of the study were Victor J. Navarro, MD; Nezam Afdhal, MD; Steven H. Bell, PhD; Abdus S. Wahed, PhD; Edward Doo, MD; Catherine M. Meyers, MD; and K. Rajender Reddy, MD. All are part of the Silymarin in NASH and C Hepatitis (SyNCH) Study Group.

The other medical centers that participated in the study were Thomas Jefferson University and University of Pennsylvania in Philadelphia, Beth Israel Deaconess Medical Center in Boston and the University of Pittsburgh.

Funding for the study came from the National Institutes of Health (NIH), the National Center for Complementary and Alternative Medicine (NCCAM), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the UNC Clinical and Translational Science Awards (CTSA). The CTSA Consortium is funded by the National Center for Advancing Translational Sciences (NCATS), part of the NIH.



ELSE PRESS RELEASES FROM THIS DATE:

Certain jobs dads do linked to higher risk of birth defects

2012-07-18
Several types of job carried out by future fathers may be linked to an increased risk of birth defects in their babies, suggests research published online in Occupational and Environmental Medicine. Previous research has linked certain occupations with a higher risk of birth defects in offspring. But it has tended to lump together very different types of defects and occupations, in order to achieve large sample sizes, with the attendant potential to skew the results, say the authors. They base their findings on data from the ongoing US National Birth Defects Prevention ...

Workplace exposure to organic solvents linked to heart defects at birth

2012-07-18
Workplace exposure to organic solvents is linked to several types of heart defects at birth, indicates research published online in Occupational and Environmental Medicine. Organic solvents are widely used for dissolving or dispersing substances, such as fats, oils, and waxes, as well as in chemical manufacturing. They are found in paints, varnishes, adhesives, degreasing/cleaning agents, dyes, polymers, plastic, synthetic textiles, printing inks and agricultural products. Most organic solvents are highly volatile and enter the body through the lungs, but can also ...

Vitamin B12 supplements may help treat hepatitis C

2012-07-18
Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body's ability to keep the virus at bay, indicates a pilot study published online in the journal Gut. The effects were particularly strong in patients whose infection was proving difficult to treat effectively, the findings showed. Between 60% and 80% of those infected with the viral liver infection HCV will go on to develop chronic hepatitis, and roughly a third of them will progress to cirrhosis and terminal liver disease. Standard treatment of interferon (peg IFN) and ribavarin ...

Man-made pores mimic important features of natural pores

2012-07-18
BUFFALO, N.Y. -- Inspired by nature, an international research team has created synthetic pores that mimic the activity of cellular ion channels, which play a vital role in human health by severely restricting the types of materials allowed to enter cells. The pores the scientists built are permeable to potassium ions and water, but not to other ions such as sodium and lithium ions. This kind of extreme selectivity, while prominent in nature, is unprecedented for a synthetic structure, said University at Buffalo chemistry professor Bing Gong, PhD, who led the study. The ...

Widely prescribed MS treatment may not slow progression of disease: VCH-UBC research

2012-07-18
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapsing‑remitting form of the disease. The study, led by Drs. Helen Tremlett, Afsaneh Shirani, Joel Oger and others, shows no strong evidence that a group of drugs, beta interferons (β-IFNs), prescribed to treat MS had a measurable ...

New video series highlights the people who fuel America's innovation pipeline

2012-07-18
The researchers reflect on their work as well as how the U.S. system for funding research makes the United States a leader. "Because of the opportunities provided by federal research funding, we are developing a generation of scientists that has no competitor on planet Earth," says Erik Dutson, executive medical director of the Center for Advanced Surgical and Interventional Technology at the University of California, Los Angeles. They also talk about the risks of decreased funding. "If you have a population of scientists that [don't] have the resources to train the ...

Girls with eating disorders regain healthy fatty acid levels when their weight normalizes

2012-07-18
A study of teenage girls with eating disorders has shown that reduced essential fatty acid levels returned to normal once the girls increased their weight to a healthy level. The research, published in the August issue of Acta Paediatrica, suggests that it is not necessary to give omega-3 polyunsaturated fatty acid supplements to adolescent girls with eating disorders. "Essential fatty acid status is altered in eating disorders that result in weight loss" explains co-author Dr Ingemar Swenne from Uppsala University Children's Hospital. "This is important because ...

Scientists find new way to induce programmed cell death, or apoptosis

2012-07-18
Researchers from the Hebrew University of Jerusalem and the Weizmann Institute of Science have developed a technique to cause apoptosis, or programmed cell death, that could lead to new approaches to treating cancer. Apoptosis is an essential defense mechanism against the spread of abnormal cells such as cancer. It is a complex process that occurs through networks of proteins that interact with each other. Cancer cells usually avoid this process due to mutations in the genes that encode the relevant proteins. The result is that the cancer cells survive and take over while ...

What it takes to be the perfect invading parasite

2012-07-18
Scientists from the Zoological Society of London (ZSL) are the first to document the characteristics of invading parasites, using malaria in New Zealand bird species. The study, published today in Ecology Letters, identifies the factors influencing the success of parasites unintentionally introduced to new environments. Avian malaria is a disease caused by species of parasites, of the genus Plasmodium, which infects birds. Just like human malaria, it is spread by mosquitoes, and the parasites spend part of their lives in red blood cells of birds. Avian malaria is common ...

In search of the key word

2012-07-18
Human beings have the ability to convert complex phenomena into a one-dimensional sequence of letters and put it down in writing. In this process, keywords serve to convey the content of the text. How letters and words correlate with the subject of a text is something Eduardo Altmann and his colleagues from the Max Planck Institute for the Physics of Complex Systems have studied with the help of statistical methods. They discovered that what denotes keywords is not the fact that they appear very frequently in a given text. It is that they are found in greater numbers only ...

LAST 30 PRESS RELEASES:

AI revives classic microscopy for on-farm soil health testing

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

[Press-News.org] Milk thistle, taken by many people for liver disease, ineffective as treatment for hepatitis C